Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT TrialAlison Jane Birtle, Robert Jones, John Chester, et al.
Clinical Genitourinary Cancer|June 3, 2017
Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden HospitalDiletta Bianchini, David Lorente, Pasquale Rescigno, et al.
The Lancet. Oncology|July 9, 2023
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trialChristopher Nutting, Laura Finneran, Justin Roe, et al.
Clinical and Translational Radiation Oncology|March 5, 2024
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM studyKobika Sritharan, Lois Daamen, Angela Pathmanathan, et al.
European Urology|December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetateRoberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Frontiers in Oncology|August 15, 2020
Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III TrialsMarco Marcello, James W Denham, Angel Kennedy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 4, 2020
Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trialsMarco Marcello, James W Denham, Angel Kennedy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2020
Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 TrialsMarco Marcello, James W Denham, Angel Kennedy, et al.
BJU International|March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancerA Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
Pageof 27